Medical Condition News

RSS

New study identifies biological mechanism driving therapy resistance in advanced prostate cancer

A multi-institutional collaborative study led by researchers at the University of Chicago and the Fred Hutchinson Cancer Center has identified a previously unknown biological mechanism that controls cell identity and treatment resistance in advanced prostate cancer.

3 Nov 2026

OGT expands range of CytoCell IVDR-certified FISH probes for hematological malignancies

OGT, a leading global provider of genomic research and diagnostic solutions, today announced the launch of four newly available IVDR-certified CytoCell® fluorescence in situ hybridization (FISH) probes as part of its ongoing commitment to transition the CytoCell FISH portfolio from CE marking under the IVD Directive (IVDD) to the IVD Regulation (IVDR) ahead of the Class C deadline of 31 December 2028.

3 Nov 2026

New dementia risk tool designed for the countries that need it most

An international team led by Northumbria University has developed and validated a simple five-factor risk score to identify older people at elevated risk of dementia in low- and middle-income countries (LMICs) - where around 60% of the world's dementia cases now occur.

3 Nov 2026

Study uncovers translation control mechanisms driving tumor growth and therapy resistance

Decoding of messenger RNA (mRNA) occurs during translation, the vital cellular process that builds proteins. Errors in this process are known to lead to cancer growth.

3 Nov 2026

Skin barrier disruption exacerbates chronic dermatological and systemic conditions

Your skin works hard for you every day, quietly shielding you from the outside world while telling a story about what is happening on the inside.

3 Nov 2026

Key innate immune protein regulates cholesterol and influences cancer treatment resistance

Scientists at the University of North Carolina Lineberger Comprehensive Cancer Center have discovered an unexpected role for a key innate immune protein, revealing how it helps regulate cholesterol levels inside cells and influences tumor growth and treatment response.

3 Nov 2026

AI-powered heart MRI measurements better predict patients' survival

Artificial intelligence (AI) measurements of heart function from MRI scans are more strongly linked to how long patients live after their scan than measurements made by clinicians, suggesting that AI could provide a useful first-line approach to measuring heart function.

2 Nov 2026

Tumor mutations may help predict relapse risk in childhood leukemia

Some cases of the most common childhood cancer, B-cell acute lymphoblastic leukemia (B-ALL), return after treatment - and genetic changes present from the start may help explain why.

2 Nov 2026

Worldwide survey reveals declining mental well-being among young people

A survey of 50,000 people across 92 countries finds global mental health may be languishing, including in the wealthiest countries, and especially among young people, who in previous generations had comparatively higher levels of mental health.

2 Nov 2026

Affordable exercise program helps people with cancer rebuild strength

When you're going through cancer treatment or recovering afterwards, rest might seem like the best medicine. But research shows that exercise can also play an important role in managing cancer recovery.

2 Nov 2026

Plant-derived compound helps restore cancer cells' sensitivity to treatment

A natural plant compound may help overcome a built-in defense that allows many cancers to resist a class of drugs designed to restore normal gene activity, according to a study by researchers at the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center.

2 Nov 2026

Global pediatric stroke burden remains high despite declining mortality

Pediatric stroke has been less recognized than adult stroke, and its risk factors, epidemiology and outcomes remain insufficiently understood.

2 Nov 2026

Understanding the causes and treatment of recurring vertigo episodes

Vertigo is a sensation that either you or your surroundings, or both, are spinning or moving when they are not. Some people confuse vertigo with dizziness, but there is a difference, explains Neil Shepard, Ph.D., an audiologist at Mayo Clinic in Minnesota.

2 Nov 2026

Gene therapy successfully corrects genetic defect in alpha-1 antitrypsin deficiency

In a landmark achievement in the field of genetic medicine, researchers have reported the very first published case in a peer-reviewed journal of a successful clinical treatment of a patient with alpha-1 antitrypsin deficiency (PiZZ) using in vivo gene therapy.

2 Nov 2026

Wearable devices and AI provide early warning signs of hypertensive crises

Using artificial intelligence (AI) to analyze patterns in measures from a portable cuff-based blood pressure monitor and health data from a wrist-worn device may help identify when adults with stage 2 high blood pressure (blood pressure ≥140/90 mm Hg) are at increased risk of a dangerously high blood pressure episode (>180/120 mm Hg with acute end-organ damage), known as a hypertensive crisis, up to three days before it occurs, according to new, independent, preliminary research to be presented at the American Heart Association's Scientific Sessions 2026.

2 Nov 2026

Long-term study supports cardiovascular safety of contemporary hormone replacement therapy

Contemporary hormone replacement therapy (HRT) was not associated with an increased risk for heart attack, stroke, blood clots or death among women ages 45 to 59, according to a large, long-term study of over 52,000 women in Israel.

2 Nov 2026

Scientists may have underestimated how much genes contribute to Alzheimer's risk

A large multi-ancestry genetic analysis identified 127 genomic loci associated with Alzheimer's disease, including 48 previously unreported loci, and implicated microglial and neuronal gene-expression patterns in disease susceptibility. The researchers estimated that common genetic variants account for 16% of Alzheimer's disease liability in European-ancestry populations, substantially higher than previous estimates, while demonstrating improved polygenic risk prediction that remained less reliable in non-European populations.

2 Nov 2026

Medical Condition News

New study identifies biological mechanism driving therapy resistance in advanced prostate cancer

OGT expands range of CytoCell IVDR-certified FISH probes for hematological malignancies

New dementia risk tool designed for the countries that need it most

Study uncovers translation control mechanisms driving tumor growth and therapy resistance

Skin barrier disruption exacerbates chronic dermatological and systemic conditions

Key innate immune protein regulates cholesterol and influences cancer treatment resistance

AI-powered heart MRI measurements better predict patients' survival

Tumor mutations may help predict relapse risk in childhood leukemia

Worldwide survey reveals declining mental well-being among young people

Affordable exercise program helps people with cancer rebuild strength

Plant-derived compound helps restore cancer cells' sensitivity to treatment

Global pediatric stroke burden remains high despite declining mortality

Understanding the causes and treatment of recurring vertigo episodes

Gene therapy successfully corrects genetic defect in alpha-1 antitrypsin deficiency

Wearable devices and AI provide early warning signs of hypertensive crises

Long-term study supports cardiovascular safety of contemporary hormone replacement therapy

Scientists may have underestimated how much genes contribute to Alzheimer's risk

Study uncovers why pulmonary hypertension patients report symptoms of cognitive decline

New hormone receptor strategy offers targeted treatment for lupus

Spatial study maps active epithelial crosstalk driving chronic periodontitis

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News